ENDACEA
Endacea, Inc. (RTP, NC), an emerging biopharmaceutical company, is developing a series of proprietary A1 adenosine receptor (AR) antagonists as drug candidates for a number of medical indications: 1) inflammation, including sepsis and asthma; and 2) renal impairment. Endacea is advancing the Company's lead compound A1 AR antagonist, L-97-1, as an i.v. anti-sepsis drug candidate and as a post-exposure medical countermeasure for plague and other biodefense indications. Endacea is also developing an endotoxin assay as a sensitive and specific biomarker to detect patients with or at risk of sepsis and for other uses. Endacea recently formed a subsidiary, Endacea Diagnostics, Inc. to develop this assay.
ENDACEA
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Address:
Davis, California, United States
Country:
United States
Website Url:
http://www.endacea.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.endacea.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K
- Host name: 205.178.133.10
- IP address: 205.178.133.10
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
